Does early passage of many bubbles consistent with an interatrial shunt indicate a large patent foramen ovale (PFO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Agitated Saline Contrast Study in Patent Foramen Ovale Assessment

Early passage of many bubbles during an agitated saline contrast study strongly indicates a large patent foramen ovale (PFO). The presence of "many bubbles" with early passage across an interatrial shunt represents a large PFO with significant right-to-left shunting, which carries higher clinical risk compared to small PFOs.

Quantification of PFO Size by Bubble Study

The size of a PFO is typically classified based on the number of microbubbles that cross the interatrial septum:

  • Small PFO: 3-19 microbubbles
  • Large PFO: ≥20 microbubbles 1

The REDUCE trial specifically defined PFO shunt sizes as 2:

  • Moderate: 6-25 microbubbles
  • Large: >25 microbubbles

Clinical Significance of Large PFOs

Large PFOs with significant right-to-left shunting have important clinical implications:

  1. Higher stroke risk: Patients with large shunts (≥20 microbubbles) have a significantly higher risk of subsequent neurologic events (31%) compared to those with small shunts (0%) 1

  2. Treatment implications: The CLOSE trial demonstrated that PFOs associated with large interatrial shunts (>30 microbubbles within three cardiac cycles) had better outcomes with closure versus medical therapy alone 2

  3. Paradoxical embolization risk: Large PFOs increase the risk of death (relative risk 2.4), ischemic stroke (relative risk 5.9), and peripheral arterial embolism (relative risk 15) in patients with conditions like pulmonary embolism 2

Diagnostic Approach

The gold standard for PFO assessment is transesophageal echocardiography (TEE) with bubble study 3, but transthoracic echocardiography (TTE) with bubble study is commonly used for initial screening:

  • Timing: Early passage is defined as bubbles appearing in the left atrium within 3-4 cardiac cycles of right atrial opacification 3
  • Quantification: Count the maximum number of microbubbles in the left heart in any single frame after contrast injection 1
  • Provocative maneuvers: Valsalva maneuver should be performed to increase sensitivity by temporarily increasing right atrial pressure 3

Clinical Management Implications

The finding of a large PFO has significant management implications:

  • Cryptogenic stroke patients ≤60 years: Consider PFO closure, particularly with high Risk of Paradoxical Embolism (RoPE) scores >6 3
  • Presence of atrial septal aneurysm: Increases embolic risk and strengthens the case for closure 2
  • Antiplatelet vs. anticoagulation: Antiplatelet therapy is standard for most cryptogenic strokes, but anticoagulation may be considered with concurrent venous thromboembolism 3

Potential Pitfalls in Interpretation

  • False positives: Pulmonary arteriovenous malformations can also cause right-to-left shunting with positive bubble studies
  • Incidental findings: PFOs are common in the general population (25-27%) 2, 4 and may be incidental rather than pathogenic
  • Patient selection: Bubble studies are frequently performed in patients who have readily identifiable causes of stroke and whose PFO is likely incidental 5

Remember that while the finding of many bubbles with early passage indicates a large PFO, clinical context remains crucial for determining its significance and appropriate management strategy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Patent Foramen Ovale (PFO) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Patent foramen ovale: a nonfunctional embryological remnant or a potential cause of significant pathology?

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.